Articles T67 Số CDD10 - HN Bệnh viện Nhi Đồng 2 - HN Trường Đại học Nguyễn Tất Thành

KHẢO SÁT MỐI TƯƠNG QUAN GIỮA TỈ SỐ BẠCH CẦU ĐA NHÂN TRUNG TÍNH TRÊN BẠCH CẦU LYMPHO VÀ MỨC ĐỘ NẶNG CỦA BỆNH Ở NHÓM BỆNH NHÂN PHỔI TẮC NGHẼN MẠN TÍNH ỔN ĐỊNH ĐANG ĐIỀU TRỊ TẠI BỆNH VIỆN NGUYỄN TRI PHƯƠNG

Le Cao Phuong Duy1,2,3,4, Ho Huynh Uy Tai1,2,3,4, Ngo Pham The Duy2,4, Tran Van Thi2,4
1 Nguyen Tri Phuong Hospital, Ho Chi Minh City
2 Nguyen Tat Thanh University
3 Bệnh viện Nguyễn Tri Phương, Thành phố Hồ Chí Minh
4 Trường Đại Học Nguyễn Tất Thành
DOI: 10.52163/yhc.v67icd10.6183
0 Views
0 Downloads
Abstract

Objective: To determine (1) the clinical characteristics of patients with stable chronic obstructive pulmonary disease (COPD) and (2) the association between the neutrophil-to-lymphocyte ratio (NLR) and the lymphocyte-to-monocyte ratio (LMR) with disease severity.

Subjects and Methods: This descriptive cross-sectional study included 100 patients with stable COPD managed at the Respiratory Outpatient Clinic, Nguyen Tri Phuong Hospital, from March 2024 to August 2024. Characteristics were compared separately across NLR and LMR groups, and Pearson correlation was used to explore the association between NLR and FEV₁. Association analyses were exploratory and were not adjusted for multiple comparisons.

Results: Most patients had mMRC ≥ 2 (81%), GOLD grade 2 airflow limitation (53%), and GOLD group B classification (61%). Median NLR and LMR were 2.30 and 2.83, respectively. In an unadjusted exploratory analysis, NLR ≥ 2.30 was associated with the high exacerbation-risk category (76% vs 48%; OR = 3.43; 95% CI: 1.46–8.06; p = 0.007). For LMR < 2.83, the corresponding difference was not statistically significant (71.43% vs 52.94%; OR = 2.22; 95% CI: 0.97–5.09; p = 0.066). There was no evidence of an association between NLR and FEV₁ (r = 0.14; p = 0.149).

Conclusion: NLR ≥ 2.30 was associated with the high exacerbation-risk category in an unadjusted exploratory analysis, whereas the corresponding association for LMR was not statistically significant. This study does not establish prognostic value or utility for monitoring treatment response.

References
[1]
Boers E, Barrett M, Su JG, et al. Global Burden of Chronic Obstructive Pulmonary Disease Through 2050. JAMA Netw Open. Dec 1 2023;6(12):e2346598. doi:10.1001/jamanetworkopen.2023.46598 Google Scholar
[2]
Nguyen Viet N, Yunus F, Nguyen Thi Phuong A, et al. The prevalence and patient characteristics of chronic obstructive pulmonary disease in non-smokers in Vietnam and Indonesia: An observational survey. Respirology. May 2015;20(4):602-11. doi:10.1111/resp.12507 Google Scholar
[3]
Fang L, Zhu J, Fu D. Predictive value of neutrophil-lymphocyte ratio for all-cause mortality in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. BMC Pulm Med. Apr 29 2025;25(1):206. doi:10.1186/s12890-025-03677-y Google Scholar
[4]
Venkatesan P. GOLD COPD report: 2025 update. Lancet Respir Med. Jan 2025;13(1):e7-e8. doi:10.1016/s2213-2600(24)00413-2 Google Scholar
[5]
Phan Thanh Thuỷ, Vũ Văn Giáp, Lê Thị Tuyết Lan, Nguyễn Viết Nhung, Ngô Quý Châu. Đặc điểm lâm sàng và tỷ lệ đợt cấp bệnh phổi tắc nghẽn mạn tính của người bệnh tại một số đơn vị quản lý ngoại trú. Tạp chí nghiên cứu Y học trường Đại học Y Hà Nội. 2022;160(12V1(2022)):228-236. doi:10.52852/tcncyh.v160i12V1.1218 Google Scholar
[6]
Wang X, Liang Q, Li Z, Li F. Body Composition and COPD: A New Perspective. Int J Chron Obstruct Pulmon Dis. 2023;18:79-97. doi:10.2147/copd.S394907 Google Scholar
[7]
Kotlyarov S. The Role of Smoking in the Mechanisms of Development of Chronic Obstructive Pulmonary Disease and Atherosclerosis. Int J Mol Sci. May 13 2023;24(10)doi:10.3390/ijms24108725 Google Scholar
[8]
Hoesterey DT, Dang H, Markovic D, et al. Neutrophil-to-Lymphocyte Ratio (NLR) as a Biomarker in Clinically Stable Chronic Obstructive Pulmonary Disease: SPIROMICS cohort. Ann Am Thorac Soc. Sep 8 2025;doi:10.1513/AnnalsATS.202412-1265OC Google Scholar
[9]
Cai C, Zeng W, Wang H, Ren S. Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR) and Monocyte-to-Lymphocyte Ratio (MLR) as Biomarkers in Diagnosis Evaluation of Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Retrospective, Observational Study. Int J Chron Obstruct Pulmon Dis. 2024;19:933-943. doi:10.2147/copd.S452444 Google Scholar
[10]
Moaleș EA, Dima-Cozma LC, Adam CA, et al. Correlations Between Inflammatory Biomarkers and COPD Severity in a Real-Life Setting. J Clin Med. Sep 15 2025;14(18)doi:10.3390/jcm14186481 Google Scholar